217 related articles for article (PubMed ID: 22927245)
21. Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in mice.
Chen TH; Kambal A; Krysiak K; Walshauser MA; Raju G; Tibbitts JF; Walter MJ
Blood; 2011 Feb; 117(5):1530-9. PubMed ID: 21123823
[TBL] [Abstract][Full Text] [Related]
22. Leptin-deficient obesity prolongs survival in a murine model of myelodysplastic syndrome.
Kraakman MJ; Kammoun HL; Dragoljevic D; Al-Sharea A; Lee MKS; Flynn MC; Stolz CJ; Guirguis AA; Lancaster GI; Chin-Dusting J; Curtis DJ; Murphy AJ
Haematologica; 2018 Apr; 103(4):597-606. PubMed ID: 29371326
[TBL] [Abstract][Full Text] [Related]
23. Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells.
Dutt S; Narla A; Lin K; Mullally A; Abayasekara N; Megerdichian C; Wilson FH; Currie T; Khanna-Gupta A; Berliner N; Kutok JL; Ebert BL
Blood; 2011 Mar; 117(9):2567-76. PubMed ID: 21068437
[TBL] [Abstract][Full Text] [Related]
24. Loss of p300 accelerates MDS-associated leukemogenesis.
Cheng G; Liu F; Asai T; Lai F; Man N; Xu H; Chen S; Greenblatt S; Hamard PJ; Ando K; Chen X; Wang L; Martinez C; Tadi M; Wang L; Xu M; Yang FC; Shiekhattar R; Nimer SD
Leukemia; 2017 Jun; 31(6):1382-1390. PubMed ID: 27881875
[TBL] [Abstract][Full Text] [Related]
25. BOK promotes erythropoiesis in a mouse model of myelodysplastic syndrome.
Kang SH; Perales O; Michaud M; Katz SG
Ann Hematol; 2019 Sep; 98(9):2089-2096. PubMed ID: 31203423
[TBL] [Abstract][Full Text] [Related]
26. Age-related epigenetic drift in the pathogenesis of MDS and AML.
Maegawa S; Gough SM; Watanabe-Okochi N; Lu Y; Zhang N; Castoro RJ; Estecio MR; Jelinek J; Liang S; Kitamura T; Aplan PD; Issa JP
Genome Res; 2014 Apr; 24(4):580-91. PubMed ID: 24414704
[TBL] [Abstract][Full Text] [Related]
27. [Clinical picture and molecular disorders in myelodysplastic (MDP) syndromes].
Rupniewska ZM
Pol Arch Med Wewn; 1992 Mar; 87(3):197-208. PubMed ID: 1523148
[No Abstract] [Full Text] [Related]
28. Ribosomal protein S14 silencing inhibits growth of acute myeloid leukemia transformed from myelodysplastic syndromes via activating p53.
Wang L; Luo J; Nian Q; Xiao Q; Yang Z; Liu L
Hematology; 2014 Jun; 19(4):225-31. PubMed ID: 24074450
[TBL] [Abstract][Full Text] [Related]
29. Clonality studies and N-ras and p53 mutation analysis of hematopoietic cells in Fanconi anemia.
Venkatraj VS; Gaidano G; Auerbach AD
Leukemia; 1994 Aug; 8(8):1354-8. PubMed ID: 8057673
[TBL] [Abstract][Full Text] [Related]
30. Loss of Toll-like receptor 2 results in accelerated leukemogenesis in the
Monlish DA; Bhatt ST; Duncavage EJ; Greenberg ZJ; Keller JL; Romine MP; Yang W; Aplan PD; Walter MJ; Schuettpelz LG
Blood; 2018 Mar; 131(9):1032-1035. PubMed ID: 29358180
[No Abstract] [Full Text] [Related]
31. Acute biphenotypic leukaemia (myeloid and null-ALL type) supervening in a myelodysplastic syndrome.
Eridani S; Chan LC; Halil O; Pearson TC
Br J Haematol; 1985 Nov; 61(3):525-9. PubMed ID: 3864486
[TBL] [Abstract][Full Text] [Related]
32. TLR2/6 signaling promotes the expansion of premalignant hematopoietic stem and progenitor cells in the NUP98-HOXD13 mouse model of MDS.
Monlish DA; Greenberg ZJ; Bhatt ST; Leonard KM; Romine MP; Dong Q; Bendesky L; Duncavage EJ; Magee JA; Schuettpelz LG
Exp Hematol; 2020 Aug; 88():42-55. PubMed ID: 32652111
[TBL] [Abstract][Full Text] [Related]
33. The NUP98-HOXD13 fusion oncogene induces thymocyte self-renewal via Lmo2/Lyl1.
Shields BJ; Slape CI; Vo N; Jackson JT; Pliego-Zamora A; Ranasinghe H; Shi W; Curtis DJ; McCormack MP
Leukemia; 2019 Aug; 33(8):1868-1880. PubMed ID: 30700838
[TBL] [Abstract][Full Text] [Related]
34. Architectural and functional heterogeneity of hematopoietic stem/progenitor cells in non-del(5q) myelodysplastic syndromes.
Chesnais V; Arcangeli ML; Delette C; Rousseau A; Guermouche H; Lefevre C; Bondu S; Diop M; Cheok M; Chapuis N; Legros L; Raynaud S; Willems L; Bouscary D; Lauret E; Bernard OA; Kosmider O; Pflumio F; Fontenay M
Blood; 2017 Jan; 129(4):484-496. PubMed ID: 27856460
[TBL] [Abstract][Full Text] [Related]
35. NPM1 ablation induces HSC aging and inflammation to develop myelodysplastic syndrome exacerbated by p53 loss.
Morganti C; Ito K; Yanase C; Verma A; Teruya-Feldstein J; Ito K
EMBO Rep; 2022 May; 23(5):e54262. PubMed ID: 35229971
[TBL] [Abstract][Full Text] [Related]
36. Targeting miR-126 disrupts maintenance of myelodysplastic syndrome stem and progenitor cells.
Wang H; Sun J; Zhang B; Zhao D; Tong H; Wu H; Li X; Luo Y; Dong D; Yao Y; McDonald T; Stein AS; Al Malki MM; Pichiorri F; Carlesso N; Kuo YH; Marcucci G; Li L; Jin J
Clin Transl Med; 2021 Oct; 11(10):e610. PubMed ID: 34709739
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia.
Liao R; Xu Y; Chen M; Chen X; Zhan X; Sun J
Hematology; 2013 Jul; 18(4):191-7. PubMed ID: 23321417
[TBL] [Abstract][Full Text] [Related]
38. The proliferation index of specific bone marrow cell compartments from myelodysplastic syndromes is associated with the diagnostic and patient outcome.
Matarraz S; Teodosio C; Fernandez C; Albors M; Jara-Acevedo M; López A; Gonzalez-Gonzalez M; Gutierrez ML; Flores-Montero J; Cerveró C; Pizarro-Perea M; Paz Garrastazul M; Caballero G; Gutierrez O; Mendez GD; González-Silva M; Laranjeira P; Orfao A
PLoS One; 2012; 7(8):e44321. PubMed ID: 22952954
[TBL] [Abstract][Full Text] [Related]
39. Opposing effects of acute versus chronic inhibition of p53 on decitabine's efficacy in myeloid neoplasms.
Tamura M; Yonezawa T; Liu X; Asada S; Hayashi Y; Fukuyama T; Tanaka Y; Kitamura T; Goyama S
Sci Rep; 2019 Jun; 9(1):8171. PubMed ID: 31160638
[TBL] [Abstract][Full Text] [Related]
40. p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia.
Kitagawa M; Yoshida S; Kuwata T; Tanizawa T; Kamiyama R
Am J Pathol; 1994 Aug; 145(2):338-44. PubMed ID: 8053492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
